{"version":"1.0","provider_name":"Imperial Medicine Blog","provider_url":"https:\/\/blogs.imperial.ac.uk\/imperial-medicine","author_name":"Nicholas Crump","author_url":"https:\/\/blogs.imperial.ac.uk\/imperial-medicine\/author\/ncrump\/","title":"Cracking the code of resistance: A new era for myeloma therapy - Imperial Medicine Blog","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"jy3gEJhyL5\"><a href=\"https:\/\/blogs.imperial.ac.uk\/imperial-medicine\/2025\/05\/28\/world-blood-cancer-day\/\">Cracking the code of resistance: A new era for myeloma therapy<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/blogs.imperial.ac.uk\/imperial-medicine\/2025\/05\/28\/world-blood-cancer-day\/embed\/#?secret=jy3gEJhyL5\" width=\"600\" height=\"338\" title=\"&#8220;Cracking the code of resistance: A new era for myeloma therapy&#8221; &#8212; Imperial Medicine Blog\" data-secret=\"jy3gEJhyL5\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/blogs.imperial.ac.uk\/imperial-medicine\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"On World Blood Cancer Day, Dr Nick Crump, Kay Kendall Leukaemia Fund Intermediate Fellow in the Hugh and Josseline Langmuir Centre for Myeloma Research, Department of Immunology and Inflammation, shares how new approaches to understanding what causes drug resistance may lead to identifying new treatments.\u00a0","thumbnail_url":"https:\/\/blogs.imperial.ac.uk\/imperial-medicine\/files\/2025\/05\/Screenshot-2025-05-27-at-14.45.54.png","thumbnail_width":874,"thumbnail_height":570}